NCT06859736

Brief Summary

This study aims to investigate the characteristics of Traditional Medicine (TM) syndromes in urticaria patients at Le Van Thinh Hospital. Urticaria is a common dermatological condition that significantly impacts patients' quality of life. However, there is limited research on TM syndrome classification in this patient group. The study will collect data on symptoms, TM syndromes, and disease severity to determine common syndromes and their associations with clinical manifestations. The study will be conducted as a cross-sectional, observational study with an estimated 200 participants. Eligible patients are those aged 18 years or older, diagnosed with acute or chronic urticaria, and willing to participate. The primary outcomes include the prevalence of TM syndromes, itching severity measured by the Visual Analogue Scale (VAS), and the correlation between TM syndromes and itching severity. The study is approved by the Institutional Review Board (IRB) of the University of Medicine and Pharmacy at Ho Chi Minh City and will be conducted from December 2024 to April 2025 at Le Van Thinh Hospital, Vietnam.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2025

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 28, 2025

Completed
1 day until next milestone

Study Start

First participant enrolled

March 1, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 5, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

March 5, 2025

Status Verified

February 1, 2025

Enrollment Period

4 months

First QC Date

February 28, 2025

Last Update Submit

February 28, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Prevalence of Traditional Medicine Syndromes in Urticaria Patients

    The study aims to determine the prevalence of Traditional Medicine (TM) syndromes in patients diagnosed with acute or chronic urticaria. Patients will be classified based on TM diagnostic criteria, including Blood Heat generating Wind, Blood Stagnation generating Wind, and Blood Deficiency generating Dry Wind. The percentage of patients presenting with each syndrome will be calculated.

    At the time of patient enrollment (Baseline assessment, within the first visit)

Study Arms (1)

Urticaria Patients with Traditional Medicine Syndrome Classification

This cohort includes patients diagnosed with acute or chronic urticaria who will be classified based on Traditional Medicine (TM) syndromes. Patients will be assessed using TM diagnostic criteria, including syndromes such as Blood Heat generating Wind, Blood Stagnation generating Wind, and Blood Deficiency generating Dry Wind. The study aims to evaluate the prevalence of these syndromes and their correlation with itching severity measured by the Visual Analogue Scale (VAS).

Eligibility Criteria

Age15 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study will recruit patients diagnosed with acute or chronic urticaria at Le Van Thinh Hospital, Vietnam. The study population will include adult patients (≥15 years old) who meet the eligibility criteria. The focus of the study is to classify Traditional Medicine (TM) syndromes in urticaria patients and explore their association with disease severity. Participants will undergo TM-based diagnostic assessment to determine the prevalence of TM syndromes such as Blood Heat generating Wind, Blood Stagnation generating Wind, and Blood Deficiency generating Dry Wind

You may qualify if:

  • Patients aged 15 years or older.
  • Diagnosed with acute or chronic urticaria based on modern medical criteria.
  • Willing to participate and provide informed consent.

You may not qualify if:

  • Patients with other dermatological conditions that may interfere with the diagnosis of urticaria.
  • Patients currently using medications that may alter symptom presentation (e.g., antihistamines, corticosteroids, immunosuppressants).
  • Patients who refuse to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Urticaria

Condition Hierarchy (Ancestors)

Skin Diseases, VascularSkin DiseasesSkin and Connective Tissue DiseasesHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
University of Medicine and Pharmacy at Ho Chi Minh City

Study Record Dates

First Submitted

February 28, 2025

First Posted

March 5, 2025

Study Start

March 1, 2025

Primary Completion

July 1, 2025

Study Completion

September 1, 2025

Last Updated

March 5, 2025

Record last verified: 2025-02